The second-year New York running back dismissed brain disease and asthma on a podcast as critics point to overwhelming medical evidence ...

Despite a wealth of available treatments to control the symptoms of chronic asthma, the lung disease has no cure. The discovery of an unexpected cause of asthma could change that. A glitch in the ...

CEO Barry Quart told investors at Oppenheimer’s 36th Annual Healthcare Life Science Conference that the company is advancing its lead asset, rademikibart, into what it described as a novel treatment a ...

The parents of a 22-year-old Wisconsin man who died after an asthma attack have filed a lawsuit against Walgreens and UnitedHealth Group’s pharmacy benefit manager after they said the price for his ...

CEO Barry Quart outlined the company’s focus on rademikibart, an IL-4 receptor alpha monoclonal antibody he described as a “next-generation DUPIXENT,” during a presentation at the Leerink Partners ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified three subtypes of chronic rhinosinusitis and trajectories of asthma and allergy with ...

Jasper Therapeutics, Inc.'s Briquilimab shows promise in treating chronic urticaria and asthma, with potential market approval by 2027, offering significant revenue opportunities in large, underserved ...

UB researchers have been awarded a five-year, $3.2 million grant to study the delivery of comprehensive asthma care to Buffalo Public Schools children with frequent asthma attacks. Funded by the ...